Oxford Quantum Circuits
Oxford Quantum Circuits Raises £260M Series C for Superconducting Quantum Computers
Oxford Quantum Circuits announced £260M in Series C financing on June 3, 2026. Oxford Quantum Circuits closed an oversubscribed £260 million Series C led by Bullhound Capital to expand in priority markets and advance fault-tolerant quantum computing.
Round details
The financing includes backing from Bullhound Capital, British Business Bank, Fynveur (advised by Invus), COFIDES, Oxford Science Enterprises, SBI, Chevron Technology Ventures, The University of Tokyo Edge Capital Partners Co.. The company did not publish a valuation with the announcement.
- Round: Series C
- Capital announced: £260M
- Headquarters: United Kingdom
How the company plans to use the capital
Oxford Quantum Circuits said the funding will be used to expand its operational presence in priority markets and to accelerate its roadmap toward commercially useful, fault-tolerant quantum computing.
Why this matters for GTM teams
The release described the round as Europe’s largest ever private funding round for a quantum computing company and said it reflects growing confidence in the commercialisation of quantum technologies.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Oxford Quantum Circuits Series C announcement.
Company Info
Investors (8)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


